HLA-C and neoplasm: (1) Peptide-MHC binding affinity (Tool: NetMHC v3.4 [ANNs]. Input: peptide sequence and HLA type)(2) Sequence coverage(3) Allele variation frequency (Tool: bam-readcount. Input: Tumor-DNA and RNA and normal-DNA)(4) Gene expression (Tool: Cufflinks. Input: RNA-seq reads)